The car analogy
Picture a cell's growth as a car. To move safely you need a working accelerator and a working brake. Two families of cancer genes map neatly onto these parts. Proto-oncogenes are the accelerators: normal, useful genes that tell a cell to grow and divide at the right times. Tumor-suppressor genes are the brakes: genes that slow division, repair damage, or order a faulty cell to self-destruct.
A crash can happen two ways: the accelerator jams down, or the brakes fail. Cancer works the same way. An accelerator jammed on is an oncogene; failed brakes mean a lost tumor suppressor. Both push a cell toward unchecked growth, but the genetics behind them are mirror images, and that difference matters enormously.
Oncogenes: one stuck accelerator is enough
When a proto-oncogene mutates so that it becomes hyperactive — switched on too strongly or too often — it becomes an oncogene. This is a gain-of-function change: the gene now does too much of its normal job. Crucially, a cell has two copies of each gene, and for an oncogene a mutation in just one copy is usually enough to push growth forward. Genetically, oncogenes act in a dominant way at the level of the cell.
How does a proto-oncogene get stuck on? A point mutation can lock the protein into an active shape. A gene can be copied too many times (amplification) so the cell makes too much of it. Or a chromosome rearrangement can fuse it to the wrong control switch — the Philadelphia chromosome in chronic myeloid leukemia is a famous example, where a translocation creates a fusion gene that drives constant cell division.
Tumor suppressors: both brakes must fail
A tumor-suppressor gene works the opposite way. Its job is to restrain growth, so cancer wants it gone. The relevant change is loss-of-function: the gene stops doing its protective work. And because you have two copies, losing one brake usually still leaves the other working. For most tumor suppressors, a cell must lose both copies before the brake truly fails — a genetically recessive behavior at the cell level.
This “need both copies” rule is the heart of the two-hit hypothesis, which we explore in guide 3. It explains a puzzle: why a person born with one already-broken brake in every cell can still be healthy for years, yet faces much higher cancer risk — they start one hit closer to losing the brake entirely.